Free Republic

Edward Gillen, 59, woke up one May morning last year and noticed a speck in his eye. The Massachusetts dad of four and beloved softball coach was just about the retire. Meanwhile, his sight was getting worse by the day. He desperately tried to nail down the cause quickly, but his vision loss deteriorated even faster. “It was Memorial Day weekend, and by June 1st, I was blind,” Gillen told the The U.S. Sun. After undergoing MRIs, CT scans and an exam from a neuro-opthalmologist, he got an answer. Doctors told him his vision loss was nonarteritic anterior ischemic optic...

A rare form of sudden and potentially permanent vision loss is becoming the latest safety question surrounding blockbuster GLP-1 drugs, with patients filing lawsuits in the U.S. even as regulators overseas have already added warnings. The condition is called nonarteritic anterior ischemic optic neuropathy, or NAION. It occurs when blood flow to the optic nerve is reduced, potentially causing abrupt vision loss that can be permanent.The complication appears to be extremely rare. The bigger issue is that researchers still disagree over whether drugs such as Ozempic and Wegovy actually cause it.That uncertainty is now moving from medical journals into courtrooms...

There’s trouble brewing beneath the GLP-1 buzz. As Americans embrace blockbuster weight-loss drugs like Ozempic and Wegovy in record numbers, providers are warning of a troubling ripple effect: patients sliding back into restrictive eating disorders — and others developing them for the first time. “I think there should be a button that you have to click saying ‘I am consciously making a choice that could really harm my health,’” Dr. Zoe Ross-Nash, a licensed clinical psychologist, told The Post. “Like on cigarette boxes, it says, ‘This could cause cancer.’ OK, well, this [drug] could cause an eating disorder.” The solemn...

Igor Chaika - newly appointed head of Russia's federal agency for foreign aid - has become an internet sensation after a press conference photo sparked a flurry of memes It was then quote-posted in a viral piece of satire on Tuesday (September 8), as users zeroed in on Chaika’s striking physique.

In a Nutshell * An oral compound called TOFA caused significant weight and fat loss in obese mice without reducing food intake or causing muscle loss, setting it apart from current obesity drugs. * TOFA worked by boosting how much energy cells burn, rather than suppressing appetite, and it also improved blood sugar, harmful blood fats, and fatty liver disease. * When combined with semaglutide or tirzepatide, TOFA outperformed either drug alone, and animals maintained their weight loss longer after TOFA treatment ended compared to semaglutide. ============================================================================================== Millions of Americans struggling with obesity have placed their hopes in a new...

Drugs prescribed for diabetes and chronic obesity such as Ozempic are increasingly sought after for quick, cosmetic weight loss, a life choice pharmacists warn can lead to serious health risks. “We have seen thin people try to come in and get it,” Dr. Carrie Leske, a licensed pharmacist in Minnesota, recently told Just the News. “As pharmacists we are supposed to use our judgment and, if need be, call the physician and try to understand what's going on, because it's supposed to only be used for obese people.” Such prescription medications, known under such popular brand names as Ozempic and...

Kate Winslet is proud to say she’s aging naturally. The “Titanic” actress, 50, weighed in on the topic of plastic surgery as she confirmed that she “hasn’t got anything” done or injected into her face... Winslet called it “devastating” that so many people, specifically other women in Hollywood, are undergoing cosmetic procedures and using weight loss drugs... “Some are making choices to be themselves, others do everything they can to not be themselves,” the Oscar winner continued. “And do they know what they are putting in? The disregard for one’s health is terrifying. It bothers me now more than ever....

Sam Altman, the co-founder of OpenAI, which launched ChatGPT, is not overweight. Gay tech billionaires rarely are. Even so, as he explained in a recent interview, he was keen to try a GLP-1, one of those drugs that have revolutionised weight loss in the past five years. You can understand why he was curious. Ozempic or Mounjaro might appear to have nothing in common with artificial intelligence, but both phenomena have created a sensation that we’re entering an era of accelerating and uncontrollable change. Alas, he screwed it up. He had someone inject him with a megadose, puked all night...

The maker of Ozempic, Novo Nordisk, has been hit with a lawsuit over allegations of wrongful death after a woman using the drug died from gastroparesis, a condition also known as stomach paralysis. Novo Nordisk denied the allegations. Marsha Ettinghoff, 76, who had been taking the weight loss drug for six months, died from stomach paralysis, a condition where food passes through the stomach slower than it should, in August 2024 after feeling ill on holiday, attorneys representing her husband, Tracy Ettinghoff said. The attorneys, from the law firm Motley Rice, said the couple believed she had food poisoning after...

As you likely know by now, Jelly Roll has undergone a dramatic body transformation, losing nearly 300 pounds. But even though he insists he didn’t use GLP-1 drugs to help with his weight loss, some people still accuse him of not being truthful about it. Last month, Jelly Roll appeared on the cover of Men’s Health, where he spoke candidly about the speculation surrounding GLP-1 medications. He explained that he didn’t use GLP-1 drugs such as Ozempic or Mounjaro to lose nearly 300 pounds, saying he instead chose to focus on confronting the emotional and psychological roots of his food...

Time for Ozempic to walk the plank? Top dietitians in Australia this week are waving a red flag about an unforeseen impact of the GLP-1 class of weight-loss drugs, including Ozempic, Wegovy and Mounjaro. In a new systematic review of existing research, led by professor Clare Collins of the Newcastle School of Health Sciences in New South Wales, Australia, it appears that very few global trials of the drugs have taken into consideration what and how much patients are eating while using them. This, experts have said, means many patients have been functionally malnourished — sometimes developing serious vitamin deficiencies...

(DCNF)—President Donald Trump announced Thursday that the price of Ozempic will fall from more than $1,000 to $199, a dramatic reduction for one of the most expensive and widely used prescription drugs in the country. Pharmacy “cash price” for a single Ozempic pen can exceed $1,300 at some U.S. outlets, according to pricing data. During the launch of Trump RX, Trump said manufacturers agreed to slash prices for popular GLP-1 weight-loss medications, insulin, asthma inhalers, and fertility drugs after sustained pressure from his administration.

The left always cares more about narrative than the truth. A split-second image can fuel outrage, define a story, and reshape public perception before facts even arrive. What happened in the Oval Office this week proves how easily that machine spins and how rare it is for decency to make the headline. Yet behind the noise lay a moment that said more about leadership than any carefully crafted address could. That moment came during a White House event on Thursday focused on expanding access to obesity treatments. In the middle of the ceremony, a guest suddenly collapsed in the Oval...

President Trump made an announcement today in the oval office highlighting two Rx companies, Eli Lilly and Company and Novo Nordisk, to dramatically reduce the prices Americans pay for some of the world’s most popular drugs. [Fact Sheet Here] Following the drug company announcement President Trump took questions from the media. The press Q&A is below and the full video including the announcement is below the fold. WATCH:

An attendee at President Donald Trump's drug pricing event on Thursday collapsed. A man identified as Novo Nordisk executive Gordon Findlay fainted just feet away from the president, who was seated at the Resolute Desk. The health scare led to the event being postponed, with White House aides quickly telling reporters that they needed to leave the Oval Office. Dr. Mehmet Oz, who serves as Trump's Administrator for the Centers for Medicare & Medicaid Services, jumped into action, guiding Findlay to the floor and then offering him medical attention. White House press secretary Karoline Leavitt didn't identify Findlay by name...

A Thursday Oval Office event, where President Donald Trump announced price reductions for weight-loss drugs, was interrupted by a health emergency. One of the attendees, Novo Nordisk executive Gordon Findlay, appeared to faint live on air during the event.

President Donald Trump this week cut deals with the drug-makers Eli Lilly and Novo Nordisk to increase access to obesity drugs in a major benefit to American public health.

Novo Nordisk is the maker behind Ozempic and WegovyThe price of Novo Nordisk's blockbuster diabetes and weight loss-related drug Ozempic will be cut, according to President Donald Trump. Trump said this week during a White House event on fertility treatments and drug pricing the price reduction will come after swift negotiations with the drugmaker. "They'll be much lower," Trump told reporters. Novo Nordisk is the maker of Ozempic and Wegovy, which have the same active ingredient, semaglutide, but they are approved for different uses. Ozempic was approved by federal health officials in 2017 and marketed for medical use in the...

From sagging jowls and sulfurous burps to deflated breasts and surprise pregnancies, the side effects of GLP-1 weight-loss drugs have ranged from subtle to strange. Now, new research suggests that these wildly popular medications may also be throwing off critical medical imaging scans, interfering with doctors’ ability to detect serious — even deadly — diseases. Experts say this could lead to delayed diagnoses and treatments for some patients, while others might undergo tests and procedures they didn’t need in the first place. Originally developed to treat Type 2 diabetes, GLP-1 meds have become a sensation due to their powerful weight-loss...

Sudden layoffs from jobs are tough to process and it gets worse when questions of employees remain unanswered. In one such case, an Indian employee detailed his sudden layoff from a US-based company in a Reddit post which has gone viral. According to the post, the employee was caught off guard by the termination, which took place on October 1, over a three-minute video call. “It was literally like any other day, woke up at 8:30, logged into work at 9 and saw a calendar invite for 11. It was a mandatory meeting with our COO for all India employees....